DK1390516T3 - Hidtil ukendte ekspressionsvektorer og anvendelser deraf - Google Patents

Hidtil ukendte ekspressionsvektorer og anvendelser deraf

Info

Publication number
DK1390516T3
DK1390516T3 DK02722308T DK02722308T DK1390516T3 DK 1390516 T3 DK1390516 T3 DK 1390516T3 DK 02722308 T DK02722308 T DK 02722308T DK 02722308 T DK02722308 T DK 02722308T DK 1390516 T3 DK1390516 T3 DK 1390516T3
Authority
DK
Denmark
Prior art keywords
expression vectors
hitherto unknown
unknown expression
hitherto
vectors
Prior art date
Application number
DK02722308T
Other languages
English (en)
Inventor
Vesna Blazevic
Mart Ustav
Urve Toots
Andres Maennik
Annamari Ranki
Ene Ustav
Kai Krohn
Marja Taehtinen
Original Assignee
Fit Biotech Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20010922A external-priority patent/FI116851B/fi
Application filed by Fit Biotech Oy filed Critical Fit Biotech Oy
Application granted granted Critical
Publication of DK1390516T3 publication Critical patent/DK1390516T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK02722308T 2001-05-03 2002-05-03 Hidtil ukendte ekspressionsvektorer og anvendelser deraf DK1390516T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20010922A FI116851B (fi) 2001-05-03 2001-05-03 Ilmentämisvektori, sen käyttöjä ja menetelmä sen valmistamiseksi sekä sitä sisältäviä tuotteita
PCT/FI2002/000379 WO2002090558A1 (en) 2001-05-03 2002-05-03 Novel expression vectors and uses thereof
US10/138,098 US7498314B2 (en) 2001-05-03 2002-05-03 Expression vectors and uses thereof

Publications (1)

Publication Number Publication Date
DK1390516T3 true DK1390516T3 (da) 2009-07-13

Family

ID=26161168

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02722308T DK1390516T3 (da) 2001-05-03 2002-05-03 Hidtil ukendte ekspressionsvektorer og anvendelser deraf

Country Status (22)

Country Link
EP (1) EP1390516B1 (da)
JP (1) JP5016779B2 (da)
CN (1) CN100430482C (da)
AP (1) AP2368A (da)
AT (1) ATE426035T1 (da)
AU (1) AU2002253198B2 (da)
BR (1) BRPI0209416A8 (da)
CA (1) CA2446260C (da)
CZ (1) CZ301691B6 (da)
DE (1) DE60231613D1 (da)
DK (1) DK1390516T3 (da)
EA (1) EA009388B1 (da)
EE (1) EE05691B1 (da)
ES (1) ES2324095T3 (da)
HU (1) HU227667B1 (da)
IL (2) IL158730A0 (da)
MX (1) MXPA03009978A (da)
NZ (1) NZ529327A (da)
PL (1) PL206097B1 (da)
SI (1) SI1390516T1 (da)
SK (1) SK287471B6 (da)
WO (1) WO2002090558A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004057005A1 (en) * 2002-12-20 2004-07-08 Fit Biotech Oyj Plc Vectors lacking an origin of replication functioning in mammalian cells and expressing growth factors
FI116068B (fi) * 2003-09-15 2005-09-15 Fit Biotech Oyj Plc Uusi selektiojärjestelmä, siinä käyttökelpoinen vektori, bakteerisolukantoja sekä menetelmä solujen valikoimiseksi
US8445431B2 (en) * 2004-06-01 2013-05-21 The Ohio State University Ligands having metal binding ability and targeting properties
DK2185192T3 (da) 2007-08-03 2019-02-18 Pasteur Institut Lentivirale genoverførselsvektorer og deres medicinske anvendelser
EP2047861B1 (en) * 2007-10-12 2019-07-31 Institut Pasteur Lentiviral gene transfer vectors suitable for iterative administration and their medicinal applications
PL2411503T3 (pl) * 2009-03-27 2018-01-31 Eidgenoessische Technische Hochschule Zuerich Salmonella enterica prezentująca n-glikan z c. jejuni lub jego pochodne
RU2653754C2 (ru) * 2012-12-06 2018-05-14 Пин Фарма, Инк. Лечение воспалительных, аутоиммунных и нейродегенеративных нарушений иммуннодепрессивными полипетидами, являющимися производными тат
CN107344962B (zh) * 2016-05-04 2021-03-02 中国科学院微生物研究所 阻遏蛋白、调控元件组和基因表达调控系统及其构建方法
WO2018185110A1 (en) 2017-04-03 2018-10-11 Fit Biotech Oy Novel expression vectors and uses thereof
WO2025233870A1 (en) * 2024-05-08 2025-11-13 Engage Biologics Inc. Non-viral dna expression systems with reduced immunogenicity and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
JP2000516472A (ja) * 1996-08-16 2000-12-12 メディカル リサーチ カウンシル 組織特異的遺伝子発現を与える自己複製型エピソーム性発現ベクター

Also Published As

Publication number Publication date
AP2003002914A0 (en) 2003-12-31
EP1390516A1 (en) 2004-02-25
EA009388B1 (ru) 2007-12-28
ATE426035T1 (de) 2009-04-15
JP5016779B2 (ja) 2012-09-05
HUP0304053A2 (hu) 2004-03-29
AU2002253198B2 (en) 2007-08-16
MXPA03009978A (es) 2005-03-07
BRPI0209416A2 (pt) 2004-03-30
BRPI0209416A8 (pt) 2018-05-08
DE60231613D1 (de) 2009-04-30
WO2002090558A1 (en) 2002-11-14
CZ20033201A3 (en) 2004-05-12
IL158730A (en) 2010-06-16
EE200300483A (et) 2004-04-15
EE05691B1 (et) 2013-12-16
EP1390516B1 (en) 2009-03-18
PL367126A1 (en) 2005-02-21
ES2324095T3 (es) 2009-07-30
AP2368A (en) 2012-02-27
CN100430482C (zh) 2008-11-05
CZ301691B6 (cs) 2010-05-26
WO2002090558A9 (en) 2003-02-06
HK1063486A1 (en) 2004-12-31
JP2004533247A (ja) 2004-11-04
SK287471B6 (sk) 2010-11-08
IL158730A0 (en) 2004-05-12
HUP0304053A3 (en) 2004-10-28
HU227667B1 (en) 2011-11-28
PL206097B1 (pl) 2010-06-30
CA2446260C (en) 2011-06-14
SK14692003A3 (sk) 2004-07-07
CN1529758A (zh) 2004-09-15
NZ529327A (en) 2006-01-27
EA200301207A1 (ru) 2004-08-26
SI1390516T1 (sl) 2009-08-31
CA2446260A1 (en) 2002-11-14

Similar Documents

Publication Publication Date Title
DK1390389T3 (da) Cripto-blokerende antistoffer og anvendelser deraf
DK1404809T3 (da) Forbedrede hudsubstitutter og anvendelser deraf
DK1554250T3 (da) Hidtil ukendt lactamer og anvendelser deraf
DK1417175T3 (da) Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf
EP1412378A4 (en) APTAMERS AND ANTIAPTAMERS
NO20024355L (no) Nukleosidforbindelser og anvendelser derav
NO20033600L (no) Meget folsomt tverrakseakselerometer
DK1578771T3 (da) Remodellering og glycokonjugering af peptider
NO20041975L (no) Bicyklisk oksopyridin og oksopyrimidinderivater
EP1441129A4 (en) TURBO PUMP
ATA15802000A (de) Pinzette
NO20055568D0 (no) Substituerte 1,4-diazepiner og anvendelser derav
FI20010922L (fi) Uusia vektoreita
DK1322597T3 (da) Fremgangsmåde og intermediære
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
DE60204749D1 (de) Abtast- und Halteschaltung
DK1390516T3 (da) Hidtil ukendte ekspressionsvektorer og anvendelser deraf
DE60220505D1 (de) Haarwaschmittel
NO20035369D0 (no) Karakterisere polypeptider
DE60112915D1 (de) Kleines tragbaren instrument
DK1317478T3 (da) Skelnen mellem GnRH-I og GnRH-II
DE60205008D1 (de) Kettelverfahren und -vorrichtung
NO20032821D0 (no) Sea-trosy og beslektede fremgangsmåter
DE10296144D2 (de) Koffer
DE60219418T8 (de) Silanylphenole und -naphthole